Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00181194 · ClinicalTrials.gov registry record
Reducing Asthma Disparities by Improving Provider-Patient Communication
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 350
- Enrollment target
NCT00181194: Completed study, sponsored by Johns Hopkins University.
NCT00181194 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 350 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00181194 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 350 participants
- Enrollment target
Study Summary
The purpose of this study will be to assess the impact of a culturally-sensitive, patient-focused asthma communication instrument (ACCI) designed to enhance provider-patient communication by prompting and guiding providers in assessments of disease severity and discussion of adherence behaviors with minority patients with asthma.
Interventions
- DEVICE Asthma Control and Communication Instrument
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2005-05 |
| Est. Completion | 2012-12 |
What the finished NCT00181194 record still lists
NCT00181194 is an observational study that tracks outcomes without assigning an intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Asthma Control and Communication Instrument is the first listed.
NCT00181194 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00181194 about?
NCT00181194 is a clinical study titled "Reducing Asthma Disparities by Improving Provider-Patient Communication". The purpose of this study will be to assess the impact of a culturally-sensitive, patient-focused asthma communication instrument (ACCI) designed to enhance provider-patient communication by prompting and guiding providers in assessments of disease severity and discussion of adherence behaviors with...
What is the current status of trial NCT00181194?
This trial is currently completed. The enrollment target is 350 participants. The study started on 2005-05. Estimated completion is 2012-12.
What interventions are being tested in trial NCT00181194?
The interventions under investigation include: Asthma Control and Communication Instrument (DEVICE).
Who is sponsoring clinical trial NCT00181194?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia